TriSalus Life Sciences, Inc. Common Stock (TLSI)
TriSalus Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer and other serious diseases. The company specializes in innovative delivery platforms designed to enhance the efficacy of cancer immunotherapies and targeted treatments, aiming to improve patient outcomes through advanced medical solutions.
Company News
ALUS, a charitable organization, has awarded the 2024 Dave Reid Award to François Allard for his exceptional leadership in agricultural stewardship. Victor Drury and Brian Maloney were recognized as runners-up for their outstanding work in environmental conservation and community engagement.
Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday. Avinger, Inc. (NASDAQ: AVGR) gained 63.9% to $9.95, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device...